ELENA AMAYA OSTOLAZA ECHABE-rekin lankidetzan egindako argitalpenak (15)

2022

  1. Boosting Cholesterol Efflux from Foam Cells by Sequential Administration of rHDL to Deliver MicroRNA and to Remove Cholesterol in a Triple-Cell 2D Atherosclerosis Model

    Small, Vol. 18, Núm. 13

2020

  1. Cholesterol efflux efficiency of reconstituted HDL is affected by nanoparticle lipid composition

    Biomedicines, Vol. 8, Núm. 10

2017

  1. Analysis of LDLR variants from homozygous FH patients carrying multiple mutations in the LDLR gene

    Atherosclerosis, Vol. 263, pp. 163-170

2016

  1. Structural changes induced by acidic pH in human apolipoprotein B-100

    Scientific Reports, Vol. 6

  2. The p.Leu167del mutation in APOE gene causes autosomal dominant hypercholesterolemia by down-regulation of LDL receptor expression in hepatocytes

    Journal of Clinical Endocrinology and Metabolism, Vol. 101, Núm. 5, pp. 2113-2121

2015

  1. Activity-associated effect of LDL receptor missense variants located in the cysteine-rich repeats

    Atherosclerosis, Vol. 238, Núm. 2, pp. 304-312

  2. Adenilato ziklasa toxinak bakterioen barneratzea eragiten du zelula ez-fagozitikoetan

    I. IkergazteNazioarteko ikerketa euskaraz. Kongresuko artikulu-bilduma: 2015eko maiatzaren 13, 14 eta 15a. Durango, Euskal Herria

  3. Adenylate Cyclase Toxin promotes bacterial internalisation into non phagocytic cells

    Scientific Reports, Vol. 5

  4. Functional characterization and classification of frequent low-density lipoprotein receptor variants

    Human Mutation, Vol. 36, Núm. 1, pp. 129-141

  5. Hiperkolesterolemia familiarra: LDLR, APOB eta PCSK9-en mutazioen balioztapen funtzionala diagnostiko zehatz baterako.

    I. IkergazteNazioarteko ikerketa euskaraz. Kongresuko artikulu-bilduma: 2015eko maiatzaren 13, 14 eta 15a. Durango, Euskal Herria

  6. Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity

    Scientific Reports, Vol. 5

2014

  1. Advantages and versatility of fluorescence-based methodology to characterize the functionality of LDLR and class mutation assignment

    PLoS ONE, Vol. 9, Núm. 11

2013

  1. Ca2+ Influx and Tyrosine Kinases Trigger Bordetella Adenylate Cyclase Toxin (ACT) Endocytosis. Cell Physiology and Expression of the CD11b/CD18 Integrin Major Determinants of the Entry Route

    PLoS ONE, Vol. 8, Núm. 9

  2. Calpain-Mediated Processing of Adenylate Cyclase Toxin Generates a Cytosolic Soluble Catalytically Active N-Terminal Domain

    PLoS ONE, Vol. 8, Núm. 6

2012

  1. Functional characterization of splicing and ligand-binding domain variants in the LDL receptor

    Human Mutation, Vol. 33, Núm. 1, pp. 232-243